Welcome Cure has raised over 4 Crores in pre-Series A round led by Inflection Point Ventures (IPV).
The funds will be utilized for growth, including talent acquisition, technology enhancement, and marketing initiatives. IPV has led the round and Welcome Cure is looking at raising over 16 crores in this on-going funding round, according to the statement.
Welcome Cure is led by a team of experienced and accomplished individuals. Dr. Jawahar Shah, the Founder, brings 45 years of clinical practice as an MD in Homeopathy and holds a post-graduate degree from London. Punit Desai, the Co-founder, and CEO, contributes his expertise with an MBA and over 10 years of entrepreneurship experience. Nidhi Desai, the Co-founder, and COO, also brings an MBA and over 10 years of entrepreneurship experience to the team. Together, they form a strong leadership that drives Welcome Cure’s mission to provide holistic healthcare solutions through their innovative platform.
Vikram Ramasubramanian, Partner, Inflection Point Ventures, says, “While Homeopathy treatment is well recognised across the globe, the number of people opting for such treatment is also growing exponentially. The main reason for such acceptance is the ability to provide treatment to the root cause, especially chronic disease which is recurring and needs utmost attention. Welcomecure with its unique healthcare solution has been able to offer its patients the much-needed treatment regardless of location. The brand itself has grown multifolds with its ability to offer seamless interaction between its patients and doctors, onboard best caregivers and experts in homeopathic medicine and providing a holistic solution all under a roof. We at IPV look forward to scaling their new age business with strategic guidance and enable the brand to benefit more and more individuals”.
Dr. Jawahar Shah, Founder, Welcome Cure says, “Homeopathy has been around for more than 200 years, grown consistently and served humanity. It enjoys acceptance from all socio-economic classes and has a wide presence across the world. As per WHO it is the 2nd largest system of medicine and used in over 100 countries. In a $9 Billion+ market there is immense potential as it’s growing at over 18% CAGR and there is a missing brand which is a name synonym to Homeopathy. Welcome Cure desires to do that and be that. Emerge as the 1st choice when anyone thinks of Homeopathy Care. With IPVs participation in Welcome Cure as an equity and growth investor we are poised to make this vision come to light.”
HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.